Subcutaneous Rituximab for the Treatment of B-Cell Hematologic Malignancies: A Review of the Scientific Rationale and Clinical Development

This article is a companion paper to G. Salles, et al., which is also published in this issue.FundingF. Hoffmann-La Roche Ltd.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research